Turning new ideas into molecules that positively impact human health

Our pipeline

Target
(Disease) Disease
Discovery
Preclinical
Clinical

FXR

Agonists

Licensed to Intercept Pharmaceuticals

Metabolic

ACMSD

Inhibitors

Metabolic

NR2F6

Antagonists

Cancer

LRH-1

Inverse agonists

Partnered with Sterling

Cancer
News View all

X-ray Structure of Human ACMSD with TES-1025

04.08.2022

Prof. Roberto Pellicciari Recipient of the EFMC Honorary Fellow Award.

08.18.2021

POR FESR 2014-2020, Asse I, Azione 1.1.1. – Avviso Ricerca 2020 – Regione Umbria

07.15.2021
Careers

We are always looking for talent and passion.

Find out if we have open positions.
Contacts

Don’t be shy!
Say Hi!

Send us an email.